Diabetes care to date: "The hits just keep on coming!"

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1801-1803

  Cefalu, William T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; C PEPTIDE; FIBROBLAST GROWTH FACTOR 19; HEMOGLOBIN A1C; OSTEOPROTEGERIN;

ADOLESCENT DISEASE; ANGIOCARDIOGRAPHY; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLINICAL RESEARCH; DIABETES MELLITUS; DIABETIC RETINOPATHY; EDITORIAL; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; MEDICAL LITERATURE; MICROANGIOPATHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PERSONALIZED MEDICINE; PROGNOSIS; PUBLICATION; ROUX Y ANASTOMOSIS;

EID: 84885966928     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0906     Document Type: Editorial

References (34)

1. Cefalu WT. Diabetes Care: "state of the union." Diabetes Care 2013;36:1-3
2. Cefalu WT, Kirkman MS. "New twist" in Diabetes Care for HbA1c reporting: "it takes two to tango"! Diabetes Care 2012; 35:2415-2416
3. Cefalu WT. Novel Communications in Diabetes: another small but significant step for Diabetes Care. Diabetes Care 2013;36: 773-774
4. CefaluWT. "TODAY" reflects on the changing "faces" of type 2 diabetes. Diabetes Care 2013;36:1732-1734
5. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and b-cell function in TODAY. Diabetes Care 2013;36:1749-1757
6. TODAY Study Group. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience. Diabetes Care 2013;36:1765-1771
7. TODAY Study Group. Treatment effects on measures of body composition in the TODAY clinical trial. Diabetes Care 2013; 36:1742-1748
8. TODAY Study Group. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 2013; 36:1758-1764
9. TODAY Study Group. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care 2013;36:1772-1774
10. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 2013;36:1735-1741
11. Linder BL, Fradkin JE, Rodgers GP. The TODAY study: an NIH perspective on its implications for research. Diabetes Care 2013;36:1775-1776
12. Tamborlane WV, Klingensmith G. Crisis in care: limited treatment options for type 2 diabetes in adolescents and youth. Diabetes Care 2013;36:1777-1778
13. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care 2013;36:1384-1395
14. Marrero DG, Ard J, Delamater AM, et al. Twenty-first century behavioral medicine: a context for empowering clinicians and patients with diabetes: a consensus report. Diabetes Care 2013;36:463-470
15. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046
16. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615
17. Marathe CS, Rayner CK, Jones KL, Horowitz M. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care 2013;36:1396-1405
18. Chakkera HA,Weil EJ, PhamP-T, Pomeroy J, Knowler WC. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care 2013;36:1406-1412
19. Franks PW, Pearson E, Florez JC. Geneenvironment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects. Diabetes Care 2013;36:1413-1421
20. Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care 2013;36:1047-1055
21. Breton M-C, Guénette L, Amiche M-A, Kayibanda J-F, Grégoire J-P, Moisan J. Burden of diabetes on the ability to work: a systematic review. Diabetes Care 2013;36:740-749
22. Ricci-Cabello I, Ruiz-Pérez I, Nevot-Cordero A, Rodríguez-BarrancoM, Sordo L, Gonç alves DC. Health care interventions to improve the quality of diabetes care in African Americans: a systematic review andmeta-analysis. Diabetes Care 2013;36:760-768
23. Ikram MK, Cheung CY, Lorenzi M, Klein R, Jones TLZ, Wong TY; NIH/JDRF Workshop on Retinal Biomarker for Diabetes Group. Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care 2013;36: 750-759
24. Malanda UL, Bot SD, Nijpels G. Selfmonitoring of blood glucose in noninsulinusing type 2 diabetic patients: it is time to face the evidence. Diabetes Care 2013;36: 176-178
25. Polonsky WH, Fisher L. Self-monitoring of blood glucose in noninsulin-using type 2 diabetic patients: right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users. Diabetes Care 2013;36:179-182
26. Butler PC, Elashoff M, Elashoff R, Gale EAM. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013; 36:2118-2125
27. Nauck MA. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks. Diabetes Care 2013;36:2126-2132
28. Bailey CJ. Interpreting adverse signals in diabetes drug development programs. Diabetes Care 2013;36:2098-2106
29. Schwartz S, DeFronzo RA. Is incretinbased therapy ready for the care of hospitalized patients with type 2 diabetes? The time has come for GLP-1 receptor agonists! Diabetes Care 2013;36:2107-2111
30. Umpierrez GE, Korytkowski M. Is incretinbased therapy ready for the care of hospitalized patients with type 2 diabetes? Insulin therapy has proven itself and is considered the mainstay of treatment. Diabetes Care 2013;36:2112-2117
31. Raz I, Riddle MC, Rosenstock J, et al. Personalized management of hyperglycemia in type 2 diabe es: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care 2013;36:1779-1788
32. Gebel E. The start of something good: the discovery of HbA1c and the American Diabetes Association Samuel Rahbar Outstanding Discovery Award. Diabetes Care 2012;35:2429-2431
33. Golden SH, Kalyani RR, Donner T. Christopher Dyer Saudek, MD: diabetes expert and implantable insulin pump pioneer. Diabetes Care 2013;36:495-497
34. Pugliese A, Skyler JS. George S. Eisenbarth: insulin and type 1 diabetes. Diabetes Care 2013;36:1437-1442